|
Market Closed -
Australian S.E.
09:10:11 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.570 AUD | -5.99% |
|
-6.27% | -53.55% |
Company Valuation: Clarity Pharmaceuticals Ltd
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 131.5 | 182.5 | 1,689 | 803.7 | 798.2 | 585.7 | - | - |
| Change | - | 38.7% | 825.73% | -52.42% | -0.69% | -26.61% | - | - |
| Enterprise Value (EV) 1 | 76.21 | 117.4 | 1,553 | 719.6 | 619.9 | 521.7 | 498.7 | 454.7 |
| Change | - | 54.11% | 1,221.95% | -53.65% | -13.85% | -15.84% | -4.41% | -8.82% |
| P/E | -5.31x | -7.37x | -35x | -12.4x | -7.35x | -4.96x | -5.9x | 10.8x |
| PBR | 1.37x | 2.64x | 11.5x | 8.91x | 4.23x | 7.98x | 9.61x | 4.24x |
| PEG | - | 7.08x | -0.6x | -0.4x | -0.2x | -0.56x | 0.4x | -0x |
| Capitalization / Revenue | 20.1x | - | - | - | - | - | 17.7x | 1.51x |
| EV / Revenue | 11.6x | - | - | - | - | - | 15.1x | 1.18x |
| EV / EBITDA | -3.22x | -4.81x | -37.1x | -10.5x | -5.44x | -4.24x | -4.91x | 5.8x |
| EV / EBIT | -3.21x | -4.79x | -36.9x | -10.5x | -5.42x | -4.22x | -4.86x | 5.84x |
| EV / FCF | -5.63x | -4.26x | -35.5x | -13.1x | -6.68x | -4.96x | -6x | 12.8x |
| FCF Yield | -17.7% | -23.5% | -2.82% | -7.64% | -15% | -20.2% | -16.7% | 7.81% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.096 | -0.095 | -0.155 | -0.201 | -0.291 | -0.3168 | -0.2662 | 0.145 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 6.554 | - | - | - | - | - | 33.03 | 386.7 |
| EBITDA 1 | -23.69 | -24.4 | -41.88 | -68.46 | -114 | -123.2 | -101.6 | 78.4 |
| EBIT 1 | -23.74 | -24.5 | -42.03 | -68.64 | -114.3 | -123.8 | -102.6 | 77.8 |
| Net income 1 | -23.75 | -24.6 | -42.32 | -64.3 | -107.2 | -120.7 | -101.1 | 55.67 |
| Net Debt 1 | -55.34 | -65.01 | -136.5 | -84.12 | -178.3 | -64 | -87 | -131 |
| Reference price 2 | 0.510 | 0.700 | 5.420 | 2.500 | 2.140 | 1.570 | 1.570 | 1.570 |
| Nbr of stocks (in thousands) | 257,939 | 260,663 | 311,646 | 321,472 | 372,971 | 373,081 | - | - |
| Announcement Date | 24/08/22 | 24/08/23 | 23/08/24 | 28/08/25 | 27/08/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.27x | - | -4.54x | - | 438M | |
| 16.97x | 6.42x | 12.3x | 1.76% | 64.38B | |
| 30.03x | 8.21x | 26.91x | 0.04% | 56.16B | |
| 37.32x | 6.62x | 19.78x | 0.87% | 54.16B | |
| 35.94x | 3.4x | 14.66x | -.--% | 45.33B | |
| 49.01x | 5.65x | 30.93x | -.--% | 42.25B | |
| -19.75x | 191.25x | -21.04x | -.--% | 40.78B | |
| 46.05x | 8.16x | 27.33x | -.--% | 33.8B | |
| 31.61x | 8.04x | 20.91x | 0.41% | 32.25B | |
| 27.18x | 5.72x | 14.84x | -.--% | 23.57B | |
| Average | 24.91x | 27.05x | 14.21x | 0.34% | 39.31B | |
| Weighted average by Cap. | 27.75x | 25.71x | 16.36x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CU6 Stock
- Valuation Clarity Pharmaceuticals Ltd
Select your edition
All financial news and data tailored to specific country editions
